BioPharma Pharma & Biopharma Manufacturing

Liminal BioSciences Update Clinical Activities for Fezagepras

Liminal BioSciences Inc. (Nasdaq: LMNL) ("Liminal BioSciences" or the "Company"), a clinical-stage biopharmaceutical company, announced today that bas...

 May 31, 2021 | News

Multiply Labs Joins forces with Cytiva to automate cell therapy manufacturing.

  Creating a fully automated robotic system will bring industrial scale reliability to cell therapy manufacturing while providing speed and flexibi...

 May 26, 2021 | News

Cytiva and Prestige Biopharma to accelerate manufacturing COVID-19 vaccines and antibody therapies.

Cytiva and Prestige Biopharma have formed a collaboration to accelerate manufacturing COVID-19 vaccines and antibody therapies. With Cytiva’s cell cu...

 May 26, 2021 | News

The Cost of Under- and Over-Coating Zinc

But for manufacturers who provide these zinc-coated products, the cost of zinc has increased substantially over the past few years, emphasizing the need to...

 May 26, 2021 | Opinion | By By Chris Burnett

COVAXIN® production volumes ramped up by Bharat Biotech, by additional 200 million

The company plans to produce 200 million doses of COVAXIN® per annum in the good manufacturing practice (GMP) facilities that are already operatio...

 May 21, 2021 | News

Basilea awarded CARB-X grant of up to USD 2.7 million

Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that it has been awarded a grant of up to USD 2.7 million from CARB-X (Combating Antibiotic-Resistan...

 May 19, 2021 | News

BD to Build New €165 Million Manufacturing Facility in Zaragoza, Spain

 BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, will build a €165 million ($200 million USD) h...

 May 18, 2021 | News

Cytiva launches sustainability plan - ‘Designing in sustainability’

Cytiva sets out a sustainability plan to positively affect people and the planet, which underpins business resilience in a fast-changing world Performan...

 May 13, 2021 | News

Advancing gene therapy by solving challenges in scale-up & manufacturing

Dr. Brophy shares additional insight about how producing viral vectors can be made more efficient, the lessons that can be learned from manufacturing mAbs ...

 May 11, 2021 | Influencers

Regulations: managing the balance of risk and rewards

Some companies see regulations and compliance guidelines as hurdles to overcome. Avantor views them as a challenge to be met, with innovation and expertise...

 May 11, 2021 | Opinion

Samsung Biologics and TG Therapeutics to enable global manufacturing of ublituximab

Samsung Biologics (KRX: 207940.KS), the world’s leading contract development and manufacturing organization and TG Therapeutics (NASDAQ: TGTX), today...

 April 26, 2021 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close